Uncategorized

Technology that helps to quickly extract and analyse genetic material could be used for cheap, accurate and mobile COVID-19 testing, including at airports and remote testing centres. ‘Dipstick’ technology, developed by the University of Queensland’s Professor Jimmy Botella and Dr Michael Mason, allows genetic material to be extracted in as little as 30 seconds, with…

A startup company developing treatments for inflammatory diseases based on a research partnership between The University of Queensland and Trinity College Dublin (TCD) has been acquired in a landmark deal – one of the largest in Australian and Irish biotech history. Inflazome has been acquired by Roche for an upfront cash payment of €380 million (about $A617 million), plus additional payments based…

Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today. CSL expects the first tranche of doses to be available by mid-2021, with additional doses following in late 2021 and early 2022,…

There is new hope for approximately 700,000 people who die each year from antibiotic resistant infections, with University of Queensland researchers discovering how bacteria share antibiotic-resistance genes. UQ’s Professor Mark Schembri said antibiotic resistant bacteria, in particular emerging ‘superbugs’, could lead to around 10 million deaths globally by 2050. “The diminishing pool of effective antibiotics makes these infections a…

The university sector will be vital in the state’s recovery from COVID-19, according to incoming University of Queensland Vice-Chancellor, Professor Deborah Terry. Professor Terry returns to UQ on Monday (3 August) after more than six years serving as Vice-Chancellor and President of Curtin University in Western Australia. Professor Terry said UQ was an incredibly strong…

The next critical phase for The University of Queensland’s COVID-19 vaccine is underway – with the research effort moving out of the lab and into human trials. Healthy adult volunteers have received the first dose of the vaccine at the Brisbane clinic of phase 1 clinical trials specialist, Nucleus Network. UQ vaccine project co-leader Professor…